Expand TAK Menu
TAK MENU

TAK Latest Press Releases

-- January 29, 2026 --

Takeda Reports Third-Quarter FY2025 Results: Updates Full Year Outlook to Reflect VYVANSE Generics Impact, OPEX Discipline and FX Tailwind; Progressing Toward Three Transformative Launches Ahead Business Wire 1:37 AM

-- January 22, 2026 --

Takeda Announces U.S. Availability of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content1 Business Wire 7:45 AM

-- January 14, 2026 --

Oncolytics Biotech Appoints John McAdory as EVP of Strategy and Operations and Yujun Wu to Lead Biostatistics Globe Newswire 9:00 AM

-- January 5, 2026 --

Takeda and Protagonist Announce Submission of New Drug Application (NDA) for Rusfertide for Treatment of Polycythemia Vera (PV) Business Wire 7:00 AM

-- December 18, 2025 --

Takeda's Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment Business Wire 3:00 AM

-- December 6, 2025 --

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera Business Wire 9:30 AM

-- December 4, 2025 --

Innovent Biologics Announces Closing of Global Strategic Partnership with Takeda for Next-Generation IO and ADC Therapies PRNewswire 6:38 PM

-- November 7, 2025 --

Takeda Presents New Data Showing Mezagitamab (TAK-079) Sustained Effect on Kidney Function 18 Months After Treatment in Primary IgA Nephropathy Business Wire 11:00 AM

-- November 3, 2025 --

New Phase 3 Data Show Takeda's Dengue Vaccine Delivers 7 Years of Sustained Protection Against Infection and Hospitalization Business Wire 7:00 AM

-- October 30, 2025 --

Takeda Reports First Half FY2025 Results, with Business Fundamentals Tracking as Planned. Updates Full Year Outlook to Reflect FX Impact and Pipeline Impairment. On Track for Multiple Regulatory Filings This Fiscal Year Business Wire 3:04 AM

-- October 27, 2025 --

HyHub and HyHub Duo Devices Now Available in the U.S. to Simplify HYQVIA Infusion Preparation Business Wire 8:35 AM

-- October 21, 2025 --

Innovent Biologics Announces Global Strategic Partnership with Takeda to Bring Innovent's Next Gen IO Backbone Therapy and ADC Molecules to the Global Market PRNewswire 8:25 PM
Takeda Enters Global Strategic Partnership with Innovent Biologics to Bolster Oncology Pipeline with Next-Generation Investigational Medicines for Treatment of Solid Tumors Business Wire 8:25 PM

-- September 23, 2025 --

20,000 + Takeda Employees Voted to Select Four New Global Corporate Social Responsibility Collaborations to Advance Climate-Resilient Health Systems in 94 Countries Business Wire 6:04 PM

-- September 16, 2025 --

Takeda and VELA to Ship Medicines Across the Atlantic Using First-of-its-Kind Wind-Powered Trimaran Business Wire 8:00 AM

-- September 11, 2025 --

Takeda Appoints Rhonda Pacheco President of the U.S. Business Unit Business Wire 8:45 AM

-- September 8, 2025 --

Takeda Presents Orexin Data from Landmark Oveporexton (TAK-861) Phase 3 Program in Narcolepsy Type 1 at World Sleep 2025 Business Wire 3:00 AM
Market Data Delayed 15 Minutes